IFN alpha-IFNAR-IN-1 hydrochloride NEW
| Price | $41 | $59 | $96 |
| Package | 1mg | 2mg | 5mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-29 |
Product Details
| Product Name: IFN alpha-IFNAR-IN-1 hydrochloride | CAS No.: 2070014-98-9 |
| Purity: 99.66% | Supply Ability: 10g |
| Release date: 2025/04/29 |
Product Introduction
Bioactivity
| Name | IFN alpha-IFNAR-IN-1 hydrochloride |
| Description | IFN alpha-IFNAR-IN-1 hydrochloride is an inhibitor of the interaction between IFN-α and IFNAR, effectively inhibiting MVA-induced IFN-α responses by BM-pDCs with an IC50 of 2-8 μM. |
| In vitro | IFN alpha-IFNAR-IN-1 hydrochloride inhibited the IFN-α responses that were elicited after treatment with CpG2216, stimulation with poly(I:C), and infection with VSV-M2, whereas the total IL-12 production was notably less affected under those conditions. IFN alpha-IFNAR-IN-1 hydrochloride specifically inhibits MVA-induced IFN-α responses by BM-pDCs. IFN alpha-IFNAR-IN-1 hydrochloride exerts immunosuppressive activity by the direct interaction with IFN-α[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 16 mg/mL (50.66 mM), Sonication is recommended. DMSO : 95 mg/mL (300.77 mM), Sonication is recommended. |
| Keywords | Interferon-α/β receptor | Interferon-alpha/beta receptor | Inhibitor | inhibit | IFNAR | IFN α-IFNAR-IN-1 Hydrochloride | IFN alpha-IFNAR-IN-1 Hydrochloride | IFN alphaIFNARIN1 hydrochloride | IFN alpha IFNAR IN 1 hydrochloride | IFN a-IFNAR-IN-1 Hydrochloride |
| Inhibitors Related | Deucravacitinib | Ginsenoside F3 | RO8191 | CP-28888 | Tilorone dihydrochloride | Anifrolumab | AX-024 hydrochloride | Interferon receptor inducer-1 | Vadimezan | Monalizumab | Cridanimod | CCCP |
| Related Compound Libraries | Bioactive Compound Library | Cytokine Inhibitor Library | Inhibitor Library | PPI Inhibitor Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2500.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-22 | |
| $15.00/10mg |
VIP3Y
|
Anko Intermational Trade Limited
|
2023-04-17 | |
| $41.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-04-29 | |
| $0.00/10mg |
Hubei Chuchang Biotech Co., Ltd.
|
2024-10-29 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY